|
Medical premium financing is poised to become a standard part of the healthcare landscape as rising treatment costs and insurance premiums make comprehensive health coverage increasingly difficult for individuals and families to afford through traditional payment methods. By allowing policyholders to spread payments over time, premium financing can improve access to broader coverage, reduce upfront financial pressure, and create greater flexibility in healthcare planning.
Kapil Garg, managing director, Mufin Green Finance said, “Medical premium financing will become a standard part of the healthcare journey over the next five years, and the clearest way to see this is to compare today's patient experience with what it looked like even five to seven years ago.”
Earlier, a family buying or renewing a health policy had to arrange the full premium as a lump sum, often at a time that did not align with their cash flow. Banks were not underwriting small ticket, short tenure premium loans, so patients either delayed renewal, under insured themselves to fit the budget, or borrowed informally from relatives or local lenders at high, unstructured rates. Brokers and agents, who were the patient's main touchpoint, had no financing product to offer alongside the policy, and their role began and ended at the sale itself, leaving the gap between a policy being needed and a premium being affordable almost entirely outside formal credit, he added.
What has closed that gap is digital infrastructure, including KYC verification, cash flow data access, and API (application programming interface) connectivity between insurers and lenders, all of which let a financing decision get underwritten in minutes rather than days.
NBFCs (Non-Banking Financial Companies) have moved into this space quickly because the underwriting stack required, including alternate data scoring, assessment of borrowers with thin or no bureau history. Premium financing is less a new lending category than a redeployment of that existing capability into a large, previously underserved pool of demand, he said.
The product itself is simple, structured as a short tenure instalment loan that converts an annual premium into monthly or quarterly payments and is usually disbursed directly to the insurer so the policy stays active without disrupting the borrower's cash flow.
Distribution has shifted just as much as underwriting, with brokers now becoming the channel through which many of these loans are offered into the renewal conversation rather than left as an afterthought, he said.
What was a fragmented, informal segment only a few years ago is now large enough to draw dedicated NBFC capital and structured debt issuances built specifically around this product. Five years out, premium financing should sit as a default option at every policy purchase or renewal, reflecting a change in accessibility rather than any change in what patients actually needed all along, said Garg.
|